Visiting Professors

VPB2_2010 | Case04

Informações:

Synopsis

ResearchToPractice.com/VPB210 – A 28-yo woman with a 2.5-cm, Grade II, ER/PR+, HER2- breast tumor is enrolled on the BETH trial of adjuvant chemo and trastuzumab with or without bevacizumab. Interview conducted by Neil Love, MD. Produced by Research To Practice.